Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease

, , , , &
Frontiers in Human Neuroscience 13 (2019)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.3389/fnhum.2019.00081

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease.Fernando Maestú, Pablo Cuesta, Omar Hasan, Alberto Fernandéz, Michael Funke & Paul E. Schulz - 2019 - Frontiers in Human Neuroscience 13.
On the reconceptualization of Alzheimer’s disease.Maartje Schermer & Edo Richard - 2018 - Bioethics 33 (1):138-145.
Descartes RV 5-8. 14. 25 diagnosis of Alzheimer's disease 132 Down syndrome 67. 132 early detection of brain pathology in Alzheimer's disease 131-143. [REVIEW]C. Bernard - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 80--151.
Research involving subjects with Alzheimer’s disease in Italy: the possible role of family members.Corinna Porteri & Carlo Petrini - 2015 - BMC Medical Ethics 16 (1):12.
To Know or Not to Know - Ethical Issues Related to Early Diagnosis of Alzheimer's Disease.Niklas Mattsson, David Brax & Henrik Zetterberg - 2010 - International Journal of Alzheimer's Disease.
KIBRA rs17070145 polymorphism and resting EEG spectral activity: Biomarkers for reduced risk of Alzheimer’s disease.Steiner Genevieve, Fernandez-Enright Francesca, Barry Robert & Barkus Emma - 2015 - Frontiers in Human Neuroscience 9.
Pre-emptive suicide, precedent autonomy and preclinical Alzheimer disease.Rebecca Dresser - 2014 - Journal of Medical Ethics 40 (8):550-551.
On the personal utility of Alzheimer’s disease-related biomarker testing in the research context.Eline M. Bunnik, Edo Richard, Richard Milne & Maartje H. N. Schermer - 2018 - Journal of Medical Ethics 44 (12):830-834.
What is a genetic cause? The example of Alzheimer’s Disease.Wim Dekkers & Marcel Olde Rikkert - 2006 - Medicine, Health Care and Philosophy 9 (3):273-284.
A Cognitive Neuroscience of Alzheimer's Disease: What Can Be Learned from Studies of visual Imagery?S. M. Kosslyn & I. E. Dror - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 49--59.
Alzheimer's Disease: Disruption of Mind-Brain Relations.S. I. Rapoport - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 86--107.
The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers.Jalayne J. Arias, Ana M. Tyler, Benjamin J. Oster & Jason Karlawish - 2018 - Journal of Law, Medicine and Ethics 46 (2):485-498.
Consciousness: Evidence of Four Components in Alzheimer's Disease.J. L. Signoret - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 144--150.
Issues Involving Informed Consent for Research Participants with Alzheimer’s Disease.Adnan Qureshi & Amer Johri - 2008 - Journal of Academic Ethics 6 (3):197-203.
The Pathogenesis of Alzheimer's Disease. What Causes Dementia?R. D. Terry - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 123--130.

Analytics

Added to PP
2019-03-08

Downloads
11 (#1,113,583)

6 months
5 (#638,139)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Michael Funke
University of South Florida

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references